MedPath

Clinical trials for revalidation of herbal compound drug on type II diabetes.

Phase 4
Conditions
Health Condition 1: null- Type 2 Diabetes Mellitus( Madhumeha)
Registration Number
CTRI/2014/12/005281
Lead Sponsor
DR C B DHANRAJ
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Type 2 DM patients

Exclusion Criteria

1.Individuals suffering from HEPATITIS-B

2.Patients suffering from AIDS.TB.

3.Persons taking any other therapy.

4.Drug abusers.

5.Persons with major psychiatric illnesses.

6.Patients suffering from heart disease,

7.Gestational diabetes mellitus.

8.Pregnant individuals.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in blood sugar levels/ increase in blood insulin levels with reduced micro/macro complications and more active and healthy life years.Timepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
Reduces the dyslipedemias and there by reduces the incidence of cardiac strokes, and other diabetic complications such as neuro and nephropathies etc.Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath